Skip to main content

Interleukin Licenses Rights to Variations in Overweight Gene from Tufts

NEW YORK, June 28 (GenomeWeb News) - Interleukin Genetics has licensed the rights to variations in a gene associated with overweight from Tufts University, the company said today.

 

Interleukin, based in Waltham, Mass., obtained exclusive rights to develop and commercialize tests and nutritional products based on variations in the perilipin gene.

 

Peripilin is a protein expressed in fat cells that influences fat metabolism. Researchers at Tufts found that women with a specific peripilin genotype weigh substantially more than other women.

The Scan

US Supports Patent Waivers

NPR reports that the Biden Administration has announced its support for waiving intellectual property protections for SARS-CoV-2 vaccines.

Vaccines Versus Variants

Two studies find the Pfizer-BioNTech SARS-CoV-2 vaccine to be effective against viral variants, and Moderna reports on booster shots to combat variants.

CRISPR for What Ails You

The Wall Street Journal writes that CRISPR-based therapies could someday be used to treat common conditions like heart attacks.

Nature Papers Review Integration of Single-Cell Assay Data, Present Approach to Detect Rare Variants

In Nature this week: review of ways to integrate data from single-cell assays, and more.